Gbola Amusa analyst

Currently out of the existing stock ratings of Gbola Amusa, 24 are a HOLD (17.52%), 99 are a BUY (72.26%), 14 are a SELL (10.22%).

Gbola Amusa

Work Performance Price Targets & Ratings Chart

Analyst Gbola Amusa, carries an average stock price target met ratio of 56.77% that have a potential upside of 77.19% achieved within 455 days. Previously, Gbola Amusa worked at CHARDAN CAPITAL.

Gbola Amusa’s has documented 261 price targets and ratings displayed on 33 stocks. The coverage was on Healthcare, Industrials, Communication Services sectors.

Most recent stock forecast was given on PASG, Passage Bio at 04-Mar-2025.

Wall Street Analyst Gbola Amusa

Analyst best performing recommendations are on SLDB (SOLID BIOSCIENCES LLC).
The best stock recommendation documented was for SLDB (SOLID BIOSCIENCES LLC) at 6/18/2018. The price target of $562.5 was fulfilled within 1 day with a profit of $121.8 (27.64%) receiving and performance score of 276.38.

Average potential price target upside

ADVM Adverum Biotechnologies AXON Axon Enterprise ESPR Esperion Therapeutics FOLD Amicus Therapeutics KRYS Krystal Biotech LJPC La Jolla Pharmaceutical Co MDCO The Medicines Company MGTX MeiraGTx Holdings PLC MRNA Moderna ONCE Spark Therapeutics PASG Passage Bio PRVB Provention Bio QURE Uniqure NV REGN Regeneron Pharmaceuticals RGNX Regenxbio SAGE Sage Therapeutic SLDB Solid Biosciences LLC VYGR Voyager Therapeutics AGTC Applied Genetic IMVT Immunovant MCRB Seres Therapeutics TSHA Taysha Gene Therapies ABUS Arbutus Biopharma Corp FBRX Forte Biosciences VBLT Vascular Biogenics Ltd ISEE IVERIC bio ADV Advantage Solutions AXGT Sio Gene Therapies IOVA Iovance Biotherapeutics KOD Kodiak Sciences LOGC LogicBio Therapeutics BOLD Audentes Therapeutics CBIO Catalyst Biosciences

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 30-Apr-2024

$5

$0.64 (14.68%)

10 months 16 days ago
(17-Nov-2025)

0/5 (0%)

$0.73 (17.10%)

Buy Since 01-Nov-2023

$5.5

$1.14 (26.15%)

$12

11 months 4 days ago
(29-Oct-2025)

1/7 (14.29%)

$1.27 (30.02%)

292

Hold Since 16-Apr-2025

$4

$-0.36 (-8.26%)

$5

11 months 5 days ago
(28-Oct-2025)

1/2 (50%)

$-0.26 (-6.10%)

168

Buy Since 18-Jul-2024

1 years 1 months 20 days ago
(13-Aug-2025)

2/3 (66.67%)

$30.52 (321.94%)

1046

Hold Since 19-Mar-2024

$4

$-0.36 (-8.26%)

$5

1 years 4 months 18 days ago
(15-May-2025)

4/6 (66.67%)

$1.95 (95.12%)

205

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?